Summit Securities Group’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$125K Buy
2025
Q3
Sell
2025
Q2
$6.75M Buy
2023
Q4
Sell
2023
Q3
$531K Buy
2023
Q2
$68K Sell
2023
Q1
$1.21M Buy
2022
Q4
$248K Buy
2014
Q2
Sell
2014
Q1
$525K Buy